← Back to catalogue
Research draft

thalassemia

vr.tr.thalassemia · XCT.STA

Let an agent explain thalassaemia and its types in general terms, relay screening, carrier testing and management information from health authorities and patient organisations, and route personal diagnosis, results and treatment questions to clinicians.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain thalassaemia and its types in general terms, relay screening, carrier testing and management information from health authorities and patient organisations, and route personal diagnosis, results and treatment questions to clinicians.

A group of inherited blood disorders in which the body makes less of one of the globin chains of haemoglobin, alpha or beta, causing anaemia that ranges from no symptoms in carriers to severe transfusion-dependent disease; common in populations from the Mediterranean, Middle East, South and Southeast Asia and Africa, and managed by transfusion, iron chelation, and in some cases stem cell transplantation or gene therapy.

What it is for: Not applicable; a disorder.

It can be explain types and inheritance in general terms; relay screening and carrier testing information; relay management options from guidelines; route personal questions to clinicians.

Distinguishing features

Reduced globin chain synthesis

Alpha and beta forms with graded severity

Autosomal recessive inheritance

Regional prevalence linked to malaria history

What it looks like

Not visible as an object; anaemia, fatigue and, in severe forms, growth and bone changes.

Physical character

carriers worldwide: hundreds of millions people - WHO estimates

inheritance: autosomal recessive pattern

How it is recognised

Inherited reduction of alpha or beta globin

Carrier state versus intermediate and major disease

Sickle cell disease and iron deficiency anaemia are different conditions

Related models

is a kind of - a disorder of haemoglobin

haemoglobinopathy

is a kind of - inheritance pattern

autosomal recessive disease

is confused with - a common misdiagnosis

iron deficiency anaemia

is related to - another haemoglobin disorder

sickle cell disease

In practice

Families and kinds

alpha thalassaemia including haemoglobin H disease and haemoglobin Bart hydrops

beta thalassaemia minor, intermedia and major

combined sickle cell beta thalassaemia

thalassaemia carrier states

Identifiers

ICD-10 D56

ICD-11 3A50

OMIM 613985 and others genetic entries

Standards and regulation

National screening programmes for carriers and newborns

Clinical guidelines from thalassaemia and haematology bodies

Blood transfusion safety standards

Rare disease frameworks

Failure modes and hazards

Iron overload from transfusion without chelation

Missed carrier status before pregnancy

Misdiagnosis as iron deficiency

Agents giving personal medical advice

Also called

Sickle cell-beta thalassemiaidiopathic hydrops fetalisHemoglobin Bartsalpha thalassemiabeta thalassemiahereditary persistence of fetal hemoglobin-beta-thalassemia syndromeAlpha thalassemia abnormal morphogenesishemoglobin H diseaseATR-16 syndromethalassemia minordelta thalassemiadominant beta-thalassemiabeta-thalassemia majorbeta-thalassemia intermedia

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Understand What thalassaemia is.

General information.

Genetics

Cause and inheritance.

Genetics

Genetics.

  1. What causes thalassaemia, and how is it inherited? definition
  2. Is the user asking about their own or their family results, which needs a clinician or genetic counsellor? boundary

Types

Types and severity.

Types

Types.

  1. How do alpha and beta forms and carrier, intermediate and major states differ? definition
  2. Which entry fits sickle cell disease? action
Screen Screening and diagnosis.

Screening.

Screening

Screening programmes.

Screening

Screening.

  1. What screening and carrier testing programmes exist, and who is offered them? provenance
  2. Which programme applies in the country in question? boundary

Diagnosis

Diagnosis.

Diagnosis

Diagnosis.

  1. How is thalassaemia diagnosed, in general terms? provenance
  2. Which entry fits haematology tests? action
Manage Treatment and living.

Care.

Treatment

Treatment.

Treatment

Treatment.

  1. What treatments do guidelines describe, from transfusion and chelation to transplantation and gene therapy? provenance
  2. Is the presentation free of personal treatment advice? boundary

Living

Living with thalassaemia.

Living

Living.

  1. What support and patient organisations exist? provenance
  2. Which entry fits patient support? action
Public health Epidemiology and research.

Population.

Epidemiology

Distribution.

Epidemiology

Epidemiology.

  1. Where is thalassaemia common, and why, with figures from WHO? measurement
  2. Which sources are cited? provenance

Research

Research.

Research

Research.

  1. What research and new therapies are under way, with attribution? provenance
  2. Which references are standard? provenance

What the second pass must settle

  • Should alpha and beta forms be separate entries?
  • How should screening programmes be linked by country?
  • The registry entry has merged aliases for specific syndromes; should they be split off?